Miracor Medical Systems GmbH Reports First-In-Man Results Using Its PICSO® System to Treat Severe Heart Attack Patients

VIENNA, Austria--(BUSINESS WIRE)--Miracor Medical Systems GmbH announced today that the first three STEMI patients enrolled in its “Prepare RAMSES” non-randomized safety and feasibility study of 40 patients have been successfully treated using PICSO® (Pressure-controlled Intermittent Coronary Sinus Occlusion) for 90 minutes following primary PCI (Percutaneous Coronary Intervention, or angioplasty) of the left anterior descendens (LAD) coronary artery. (Click here for video animation of PICSO®.)